MedTrace Logo

Corticosteroids for Acute Migraine in the Emergency Department

NCT02847494 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2019-01-08

Study results available
· View outcomes & findings →

Summary

This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.

Conditions

Interventions

DRUG

methylprednisolone acetate

methylprednislone acetate 160mg intramuscular injection

DRUG

metoclopramide

metoclopramide 10mg intravenous infusion over 15 minutes

DRUG

Dexamethasone

dexamethasone 10mg intramuscular injection

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Benjamin W Friedman, MD, MS · Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2017-09-21
Completion
2017-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02847494 on ClinicalTrials.gov